Skip to main content

Lip Augmentation

2
Pipeline Programs
3
Companies
7
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
2
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Symbio Pharmaceuticals
3 programs
2
PN40082Phase 31 trial
PN40082Phase 31 trial
PN40082N/A1 trial
Active Trials
NCT04032977Completed158Est. May 2019
NCT04029545Terminated5Est. Dec 2019
NCT04029519Completed84Est. Aug 2019
Galderma
GaldermaTX - Dallas
3 programs
Hyaluronic acidN/A1 trial
New Dermal FillerN/A1 trial
Restylane KysseN/A1 trial
Active Trials
NCT03967444Completed59Est. Sep 2019
NCT03320824Completed273Est. Apr 2019
NCT05342753Completed22Est. Nov 2024
AbbVie
AbbVieNORTH CHICAGO, IL
1 program
hyaluronic acid gelN/A1 trial
Active Trials
NCT01197495Completed213Est. Jun 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Symbio PharmaceuticalsPN40082
Symbio PharmaceuticalsPN40082
GaldermaRestylane Kysse
GaldermaHyaluronic acid
Symbio PharmaceuticalsPN40082
GaldermaNew Dermal Filler
AbbViehyaluronic acid gel

Clinical Trials (7)

Total enrollment: 814 patients across 7 trials

NCT04029545Symbio PharmaceuticalsPN40082

A Multicenter, Double-blind, Randomized, Controlled, Roll-over Retreatment Study of the Safety and Pain Associated With Injections of PN40082, RV001 With Topical Anesthetic or RV001 for Lip Augmentation

Start: Jun 2019Est. completion: Dec 20195 patients
Phase 3Terminated
NCT04029519Symbio PharmaceuticalsPN40082

A Multicenter, Open-Label Retreatment Study of the Safety and Effectiveness of PN40082 for Lip Augmentation

Start: Dec 2018Est. completion: Aug 201984 patients
Phase 3Completed
NCT05342753GaldermaRestylane Kysse

Safety and Effectiveness of Restylane® Kysse for Lip Augmentation in Chinese Subjects

Start: Jun 2022Est. completion: Nov 202422 patients
N/ACompleted
NCT03967444GaldermaHyaluronic acid

Study to Evaluate Satisfaction After Treatment With Kysse

Start: May 2019Est. completion: Sep 201959 patients
N/ACompleted
NCT04032977Symbio PharmaceuticalsPN40082

Safety and Effectiveness of PN40082 for Lip Augmentation

Start: Jul 2018Est. completion: May 2019158 patients
N/ACompleted
NCT03320824GaldermaNew Dermal Filler

New Dermal Filler for Lip Augmentation

Start: Nov 2017Est. completion: Apr 2019273 patients
N/ACompleted
NCT01197495AbbViehyaluronic acid gel

Safety and Effectiveness of Juvederm(R) Ultra XC Injectable Gel for Lip Augmentation

Start: Aug 2010Est. completion: Jun 2015213 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 late-stage (Phase 3) programs, potential near-term approvals
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.